Traws Pharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $2,733 | $57 | $57 |
Gross Profit | 2,733 | 56 | 55 | |
EBITDA | -3,962 | -2,496 | 21,491 | -8,473 |
EBIT | -2,498 | 21,490 | -8,475 | |
Net Income | -3,035 | -625 | 15,083 | -8,475 |
Net Change In Cash | 0 | 2,733 | 57 | 57 |
Free Cash Flow | -4,011 | -5,979 | -5,437 | -4,040 |
Cash | 6,420 | 13,081 | 15,937 | 21,338 |
Basic Shares | 8,819 | 5,820 | 7,215 | 961 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $226 | $226 | $226 | $226 |
Gross Profit | 214 | 226 | 226 | 226 |
EBITDA | -166,511 | -20,282 | -19,613 | -16,482 |
EBIT | -166,523 | -20,298 | -19,627 | -16,496 |
Net Income | -54,674 | -18,948 | -18,964 | -16,163 |
Net Change In Cash | 226 | 226 | 226 | 226 |
Free Cash Flow | -29,792 | -17,946 | -16,294 | -19,487 |
Cash | 21,338 | 20,821 | 38,757 | 55,070 |
Basic Shares | 1,552 | 839 | 836 | 673 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.34 |
2025-06-30 | -$0.16 |
2025-03-31 | $22.44 |
2024-12-31 | $26.60 |
